Literature DB >> 15088989

[How dangerous is hormone replacement therapy (HRT) in menopause?].

Johannes C Huber1.   

Abstract

Mesh：

Year:  2004        PMID： 15088989     DOI： 10.1007/bf03040481

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN： 0043-5325            Impact factor:   1.704


× No keyword cloud information.
  6 in total

Review 1.  Production and actions of estrogens.

Authors:  Christian J Gruber; Walter Tschugguel; Christian Schneeberger; Johannes C Huber
Journal:  N Engl J Med       Date:  2002-01-31       Impact factor: 91.245

2.  Hormone replacement therapy and breast cancer.

Authors:  D M Gruber; M O Sator; J C Huber
Journal:  Lancet       Date:  1997-11-29       Impact factor: 79.321

3.  Postmenopausal hormone therapy and mortality.

Authors:  F Grodstein; M J Stampfer; G A Colditz; W C Willett; J E Manson; M Joffe; B Rosner; C Fuchs; S E Hankinson; D J Hunter; C H Hennekens; F E Speizer
Journal:  N Engl J Med       Date:  1997-06-19       Impact factor: 91.245

4.  Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.

Authors:  Jacques E Rossouw; Garnet L Anderson; Ross L Prentice; Andrea Z LaCroix; Charles Kooperberg; Marcia L Stefanick; Rebecca D Jackson; Shirley A A Beresford; Barbara V Howard; Karen C Johnson; Jane Morley Kotchen; Judith Ockene
Journal:  JAMA       Date:  2002-07-17       Impact factor: 56.272

5.  HABITS (hormonal replacement therapy after breast cancer--is it safe?), a randomised comparison: trial stopped.

Authors:  L Holmberg; H Anderson
Journal:  Lancet       Date:  2004-02-07       Impact factor: 79.321

6.  Breast cancer and hormone-replacement therapy in the Million Women Study.

Authors:  Valerie Beral
Journal:  Lancet       Date:  2003-08-09       Impact factor: 79.321
  6 in total
  1 in total

1.  [Evidence based basis of decision making for or against a postmenopausal hormone treatment].

Authors:  Eva Rásky
Journal:  Wien Klin Wochenschr       Date:  2004-07-31       Impact factor: 1.704
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.